Please login to the form below

Not currently logged in
Email:
Password:

transfers of value

This page shows the latest transfers of value news and features for those working in and with pharma, biotech and healthcare.

The future of biotech

The future of biotech

This has not affected technology transfers, an important method of transfering value. ... Italy has introduced innovative schemes to link pricing with value and use of registries.

Latest news

  • Lundbeck challenge to EC pay-for-delay ruling fails Lundbeck challenge to EC pay-for-delay ruling fails

    Lundbeck challenge to EC pay-for-delay ruling fails. Court upholds 94m fine for paying off firms to delay launch of Celexa generics. ... value transfers and other inducements," and that the behaviour amounted to a "a buying-off of competition".

  • Counting value under the US Sunshine Act Counting value under the US Sunshine Act

    In February 2013, the Centers for Medicare and Medicaid Services (CMS) published its final rule requiring manufacturers of medicines and medical devices to report payments exceeding $10 or other 'transfers of ... The code requires companies to disclose

  • Pharma paid £38.5m to UK healthcare professionals in 2013 Pharma paid £38.5m to UK healthcare professionals in 2013

    This regulation requires that companies disclose all 'transfers of value' to HCPs for consultancy fees, payment for travel or congress fees etc, as well as a complete ban on all 'gifts'. ... Companies working in the US now also face disclosure of HCP

  • Pharma companies differ on Sunshine Act payment definition Pharma companies differ on Sunshine Act payment definition

    Pharma companies differ on Sunshine Act payment definition. Confusion about whether provision of editorial services is transfer of value. ... or transfers of value - made to physicians.

  • EFPIA: Disclose payments or face legislation EFPIA: Disclose payments or face legislation

    EFPIA's code of practice is set to come into force at the beginning of 2014 and includes requirements that companies disclose all 'transfers of value' to HCPs for consultancy fees, ... and healthcare organisations from pharma companies as well as industry

More from news
Approximately 1 fully matching, plus 10 partially matching documents found.

Latest Intelligence

  • Lessons from a squirrel Lessons from a squirrel

    As costs are tightly managed and concerns about transfers of value reporting may result in fewer HCPs travelling to events, how can we be more creative in developing valuable distance-learning ... When a payer does not see the value of a new drug or

  • Counting down to the EFPIA Disclosure Code Counting down to the EFPIA Disclosure Code

    The pan-Europe regulation requires all EFPIA members to reveal any 'transfers of value' made in 2015 by summer next year. ... But this is a massive undertaking, involving an enormous investment of time and resources.

  • 10 ways to meet event disclosure rules 10 ways to meet event disclosure rules

    companies will be duty bound to publicly disclose all transfers of value (TOV) made to HCPs and HCOs in accordance with the 2014 EFPIA Disclosure code. ... 10 Ways … to meet event disclosure rules focuses on the disclosure of meetings and eventsspend,

  • 10 ways to meet event disclosure rules 10 ways to meet event disclosure rules

    companies will be duty bound to publicly disclose all transfers of value (TOV) made to HCPs and HCOs in accordance with the 2014 EFPIA Disclosure code. ... 10 Ways … to meet event disclosure rules focuses on the disclosure of meetings and eventsspend,

  • The changing regulatory environment The changing regulatory environment

    Key Code updates. EFPIA Code demands that industry declares all transfers of value to healthcare professionals and healthcare organisations. ... EFPIA believes that interactions between the pharmaceutical industry and healthcare professionals have a

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

  • Finding the Value for Pharma in Connected Health

    Finding the Value for Pharma in Connected Health. The value of a future connected healthcare system may be self-evident, but finding the value in it for pharma is more difficult ... Download 'Finding the value in digital' article from Pharma

More from PMHub
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Six Degrees Medical Consulting

Partnering with top global pharmaceutical companies, we push the boundaries to create meaningful, impactful and lasting learning opportunities. We leverage...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics